ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,073Medicare Part D Prescriptions Filled, Including Refills

Rank: 341 out of 1121

$604K Total Retail Price of All Prescriptions

Rank: 287 out of 1121

691 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 691 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 691 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 5,536 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 407 196 S3 1 3
SIMVASTATIN 375 227 2 1
AMLODIPINE BESYLATE 362 271 3 5
FUROSEMIDE 295 169 4 7
OMEPRAZOLE 284 124 5 6
LISINOPRIL 277 174 6 4
METFORMIN HCL 241 129 7 8
LEVOTHYROXINE SODIUM 238 151 8 2
PROAIR HFA 198 101 9 48
PLAVIX 173 82 10 42
CRESTOR 167 87 11 28
GABAPENTIN 164 67 12 13
METOPROLOL TARTRATE 146 71 13 9
HYDROCHLOROTHIAZIDE 140 69 14 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 55 15 31
SPIRIVA 122 82 16 49
ATORVASTATIN CALCIUM 115 66 17 15
SINGULAIR 115 46 17 78
NEXIUM 114 75 19 24
GLYBURIDE 106 75 R 20 51
ZOLPIDEM TARTRATE 105 40 21 19
WARFARIN SODIUM 103 38 22 11
TRAMADOL HCL 101 52 23 25
DIOVAN 92 51 24 45
RANITIDINE HCL 92 58 24 33
SYMBICORT 88 52 26 148
CLONIDINE HCL 87 46 27 39
PANTOPRAZOLE SODIUM 81 46 28 29
POTASSIUM CHLORIDE 81 25 28 12
VENTOLIN HFA 81 39 28 92
BENAZEPRIL HCL 81 56 28 41
FENOFIBRATE 79 31 32 71
CITALOPRAM HBR 78 47 33 18
DIOVAN HCT 77 52 34 90
TAMSULOSIN HCL 76 54 35 32
PRAVASTATIN SODIUM 75 34 36 14
CARVEDILOL 73 42 37 20
ALLOPURINOL 70 52 38 30
METOPROLOL SUCCINATE 70 49 38 23
ATENOLOL 69 42 40 16
PEN NEEDLE 69 31 40 137
AMLODIPINE BESYLATE-BENAZEPRIL 69 44 40 65
KLOR-CON 10 66 51 43 69
ADVAIR DISKUS 64 38 44 64
TRICOR 64 25 44 126
CLOPIDOGREL 63 39 46 27
JANUVIA 63 41 46 81
CYCLOBENZAPRINE HCL 60 27 R 48 83
PROMETHAZINE HCL 60 15 R 48 67
OXYBUTYNIN CHLORIDE 59 21 50 128
LOSARTAN POTASSIUM 59 46 50 17
INSULIN SYRINGE 57 35 52 77
FAMOTIDINE 57 28 52 63
PHENYTOIN SODIUM EXTENDED 55 21 54 135
POLYETHYLENE GLYCOL 3350 52 32 55 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.